Effect of Birth on Immunological Parameters in Cord Blood
NCT ID: NCT03134768
Last Updated: 2020-04-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2016-05-02
2017-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurodegeneration in Newborns After Anesthetics
NCT03064607
Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates
NCT03053076
New Procedure to Reduce Mother-newborn Separation
NCT06594458
Oropharyngeal Administration of Colostrum to Extremely Low Gestational Age Newborns
NCT01536093
Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care
NCT00127699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This is not an interventional study
This is an observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Antenatal antibiotics treatment (2 weeks prior to birth)
* Diabetes mellitus requiring insulin treatment during pregnancy
* Uncontrollable Hyperthyroidism during pregnancy
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danone Asia Pacific Holdings Pte, Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Sandalova, PhD
Role: STUDY_CHAIR
Danone Asia Pacific Holdings Ltd
Anne Goh, MD
Role: STUDY_CHAIR
KK Hospital
Mei Chin Chua, MD
Role: PRINCIPAL_INVESTIGATOR
KK Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAE.1C.D.10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.